Enovis Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 7,367

Employees

  • Stock Symbol
  • ENOV

Stock Symbol

  • Investments
  • 39

  • Share Price
  • $30.54
  • (As of Wednesday Closing)

Enovis General Information

Description

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Contact Information

Website
www.enovis.com
Formerly Known As
Colfax Corporation
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States
+1 (302)
Primary Industry
Therapeutic Devices
Stock Exchange
NYS
Vertical(s)
Manufacturing, Industrials
Corporate Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States
+1 (302)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enovis Stock Performance

As of 16-Jul-2025, Enovis’s stock price is $30.54. Its current market cap is $1.74B with 57.1M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$30.54 $30.90 $28.83 - $49.83 $1.74B 57.1M 1.31M -$13.95

Enovis Financials Summary

As of 31-Mar-2025, Enovis has a trailing 12-month revenue of $2.15B.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 3,534,774 3,833,709 3,493,431 3,169,473
Revenue 2,150,191 2,107,623 1,707,197 1,563,101
EBITDA (471,909) (481,028) 169,730 241,693
Net Income (809,462) (825,494) (33,261) (13,292)
Total Assets 4,875,034 4,718,777 4,509,334 4,273,248
Total Debt 1,458,868 1,404,301 536,416 334,819
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enovis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enovis‘s full profile, request access.

Request a free trial

Enovis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient car
Therapeutic Devices
Wilmington, DE
7,367 As of 2024

Warsaw, IN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enovis Competitors (1)

One of Enovis’s competitors is Zimmer Biomet Holdings, a Corporation company based in Warsaw, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zimmer Biomet Holdings Corporation Warsaw, IN
You’re viewing 1 of 1 competitors. Get the full list »

Enovis Patents

  • 1,105

    Total Documents Applications and Grants

  • Total Patents Families

  • 446

    Granted

  • 72

    Pending

  • Expiring in next 12 mo

Enovis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1084067-S1 Torch handle Active 15-Feb-2023
US-20240130030-A1 Methods for mixing fluids for a plasma cutting torch Pending 17-Oct-2022
US-D1067289-S1 Welding component Active 14-Oct-2022
US-20240123538-A1 Pistol grip for a processing torch Pending 12-Oct-2022
US-20240109145-A1 Wire feeder to torch communication Pending 30-Sep-2022 B23K9/0953
To view Enovis’s complete patent history, request access »

Enovis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enovis Investments & Acquisitions (39)

Enovis’s most recent deal was a Merger/Acquisition with Limacorporate for . The deal was made on 03-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Limacorporate 03-Jan-2024 Merger/Acquisition Therapeutic Devices
Precision AI Australia 05-Oct-2023 Merger/Acquisition Therapeutic Devices
SEAL External Fixation 20-Jul-2023 Merger/Acquisition Therapeutic Devices
Novastep 28-Jun-2023 Merger/Acquisition Other Devices and Supplies
Insight Medical Systems 05-Jul-2022 Merger/Acquisition Surgical Devices
You’re viewing 5 of 39 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Enovis ESG

Risk Overview

Risk Rating

Updated September, 17, 2024

31.09 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,697

Rank

Percentile

Healthcare

Industry

of 562

Rank

Percentile

Medical Devices

Subindustry

of 194

Rank

Percentile

To view Enovis’s complete esg history, request access »

Enovis Exits (1)

Enovis’s most recent exit was on 09-Jul-2013 from Clarus Fluid Intelligence. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Clarus Fluid Intelligence 09-Jul-2013 Completed
To view Enovis’s complete exits history, request access »

Enovis Affiliates

Subsidiaries (14)

Name Industry Location Year Founded
Precision AI Australia Fortitude Valley, Australia 2019
Insight Medical Systems Austin, TX 2016
360 Med Care Frenchs Forest, Australia 2015
Novastep Englewood Cliffs, NJ 2015
Fairmount Automation West Conshohocken, PA 1996
You’re viewing 5 of 14 affiliates. Get the full list.  »

Enovis FAQs

  • When was Enovis founded?

    Enovis was founded in 1995.

  • Where is Enovis headquartered?

    Enovis is headquartered in Wilmington, DE.

  • What is the size of Enovis?

    Enovis has 7,367 total employees.

  • What industry is Enovis in?

    Enovis’s primary industry is Therapeutic Devices.

  • Is Enovis a private or public company?

    Enovis is a Public company.

  • What is Enovis’s stock symbol?

    The ticker symbol for Enovis is ENOV.

  • What is the current stock price of Enovis?

    As of 16-Jul-2025 the stock price of Enovis is $30.54.

  • What is the current market cap of Enovis?

    The current market capitalization of Enovis is $1.74B.

  • What is Enovis’s current revenue?

    The trailing twelve month revenue for Enovis is $2.15B.

  • Who are Enovis’s competitors?

    Zimmer Biomet Holdings is a competitor of Enovis.

  • What is Enovis’s annual earnings per share (EPS)?

    Enovis’s EPS for 12 months was -$13.95.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »